Topical Interferon or Surgical Excision for the Management of Primary Ocular Surface Squamous Neoplasia

Ophthalmology

Volumn 115, Issue 8, 2008, Pages

  Sturges, Amber ^a,b   Butt, Amir L ^a,c   Lai, James E ^a,b   Chodosh, James ^a,b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONJUNCTIVITIS; CONTROLLED STUDY; EYE TUMOR; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERVENTION STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY OCULAR SURFACE SQUAMOUS NEOPLASIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TIME;

EID: 48149098574     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.01.006     Document Type: Article

References (72)

1. Lee G.A., and Hirst L.W. Ocular surface squamous neoplasia. Surv Ophthalmol 39 (1995) 429-450
2. Kiire C.A., and Dhillon B. The aetiology and associations of conjunctival intraepithelial neoplasia. Br J Ophthalmol 90 (2006) 109-113
3. Napora C., Cohen E.J., Genvert G.I., et al. Factors associated with conjunctival intraepithelial neoplasia: a case control study. Ophthalmic Surgery 21 (1990) 27-30
4. Erie J.C., Campbell R.J., and Liesegang T.J. Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology 93 (1986) 176-183
5. Lee G.A., Williams G., Hirst L.W., and Green A.C. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 101 (1994) 360-364
6. Vann R.R., and Karp C.L. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 106 (1999) 91-97
7. McDonnell J.M., Mayr A.J., and Martin W.J. DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med 320 (1989) 1442-1446
8. Lauer S.A., Malter J.S., and Meier J.R. Human papillomavirus type 18 in conjunctival intraepithelial neoplasia. Am J Ophthalmol 110 (1990) 23-27
9. Odrich M.G., Jakobiec F.A., Lancaster W.D., et al. A spectrum of bilateral squamous conjunctival tumors associated with human papillomavirus type 16. Ophthalmology 98 (1991) 628-635
10. Waddell K.M., Lewallen S., Lucas S.B., et al. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 80 (1996) 503-508
11. Scott I.U., Karp C.L., and Nuovo G.J. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology 109 (2002) 542-547
12. Goedert J.J., and Cote T.R. Conjunctival malignant disease with AIDS in USA. [letter]. Lancet 346 (1995) 257-258
13. Karp C.L., Scott I.U., Chang T.S., and Pflugfelder S.C. Conjunctival intraepithelial neoplasia: a possible marker for human immunodeficiency virus infection?. Arch Ophthalmol 114 (1996) 257-261
14. Kestelyn P., Stevens A., Ndayambaje A., et al. HIV and conjunctival malignancies. [letter]. Lancet 336 (1990) 51-52
15. Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 345 (1995) 695-696
16. Wabinga H.R., Parkin D.M., Wabwire-Mangen R., and Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 82 (2000) 1585-1592
17. Newton R., Ziegler J., Beral V., et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer 92 (2001) 622-627
18. Waddell K.M., Downing R.G., Lucas S.B., and Newton R. Corneo-conjunctival carcinoma in Uganda. Eye 20 (2006) 893-899
19. Pizzarello L.D., and Jakobiec F.A. Bowen's disease of the conjunctiva: a misnomer. In: Jakobiec F.A. (Ed). Ocular and Adnexal Tumors (1978), Aesculapius, Birmingham, AL 553-571
20. Fraunfelder F.T., and Wingfield D. Therapy of intraepithelial epitheliomas and squamous cell carcinoma of the limbus. Trans Am Ophthalmol Soc 78 (1980) 290-300
21. Fraunfelder F.T., and Wingfield D. Management of intraepithelial conjunctival tumors and squamous cell carcinomas. Am J Ophthalmol 95 (1983) 359-363
22. Tunc M., Char D.H., Crawford B., and Miller T. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol 83 (1999) 98-103
23. Sudesh S., Rapuano C.J., Cohen E.J., et al. Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea 19 (2000) 278-283
24. McKelvie P.A., Daniell M., McNab A., et al. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol 86 (2002) 168-173
25. Tabin G., Levin S., Snibson G., et al. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 104 (1997) 485-492
26. Shields J.A., Shields C.L., and De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. Arch Ophthalmol 115 (1997) 808-815
27. Frucht-Pery J., and Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 117 (1994) 164-168
28. Wilson M.W., Hungerford J.L., George S.M., and Madreperla S.A. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 124 (1997) 303-311
29. Tseng S.H., Tsai Y.Y., and Chen F.K. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C. Cornea 16 (1997) 595-597
30. Frucht-Pery J., Sugar J., Baum J., et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology 104 (1997) 2085-2093
31. Grossniklaus H.E., and Aaberg Sr. T.M. Mitomycin C treatment of conjunctival intraepithelial neoplasia. Am J Ophthalmol 124 (1997) 381-383
32. Heigle T.J., Stulting R.D., and Palay D.A. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 124 (1997) 397-399
33. Gebhardt D.O. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. [letter]. Am J Ophthalmol 125 (1998) 416-417
34. Haas K., Ben-Dor D., and Levartovsky S. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C. Arch Ophthalmol 117 (1999) 544-545
35. Rozenman Y., and Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical drops of mitomycin C. Cornea 19 (2000) 1-6
36. Daniell M., Maini R., and Tole D. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin Experiment Ophthalmol 30 (2002) 94-98
37. Papandroudis A.A., Dimitrakos S.A., and Stangos N.T. Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia. Cornea 21 (2002) 715-717
38. Shields C.L., Naseripour M., and Shields J.A. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 133 (2002) 601-606
39. Siganos C.S., Kozobolis V.P., and Christodoulakis E.V. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea 21 (2002) 12-16
40. Rosner M., Hadar I., and Rosen N. Successful treatment with mitomycin C eye drops for conjunctival diffuse intraepithelial neoplasia with sebaceous features. Ophthal Plast Reconstr Surg 19 (2003) 477-479
41. Di Pascuale M.A., Espana E.M., and Tseng S.C. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles. Cornea 23 (2004) 89-92
42. Huerva V., Mateo A.J., Mangues I., and Jurjo C. Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia. Cornea 25 (2006) 1220-1223
43. Hirst L.W. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia. Early resolution. Ophthalmology 114 (2007) 976-982
44. de Keizer R.J., de Wolff-Rouendaal D., and van Delft J.L. Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva and eyelid. Doc Ophthalmol 64 (1986) 31-42
45. Yeatts R.P., Ford J.G., Stanton C.A., and Reed J.W. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology 102 (1995) 1338-1344
46. Midena E., Angeli C.D., Valenti M., et al. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol 84 (2000) 268-272
47. Yeatts R.P., Engelbrecht N.E., Curry C.D., et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 107 (2000) 2190-2195
48. Yamamoto N., Ohmura T., Suzuki H., and Shirasawa H. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin-C. Ophthalmology 109 (2002) 249-252
49. Maskin S.L. Regression of limbal epithelial dysplasia with topical interferon. [letter]. Arch Ophthalmol 112 (1994) 1145-1146
50. Hu F.R., Wu M.J., and Kuo S.H. Interferon treatment for corneolimbal squamous dysplasia. Am J Ophthalmol 125 (1998) 118-119
51. Karp C.L., Moore J.K., and Rosa Jr. R.H. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology 108 (2001) 1093-1098
52. Schechter B.A., Schrier A., Nagler R.S., et al. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea 21 (2002) 6-11
53. Kobayashi A., Yoshita T., Uchiyama K., et al. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b. Jpn J Ophthalmol 46 (2002) 215-217
54. Boehm M.D., and Huang A.J. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology 111 (2004) 1755-1761
55. Esquenazi S., Fry C.L., and Holley E. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b. [letter]. Br J Ophthalmol 89 (2005) 1221
56. Holcombe D.J., and Lee G.A. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. Am J Ophthalmol 142 (2006) 568-571
57. Nemet A.Y., Sharma V., and Benger R. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C. Clin Experiment Ophthalmol 34 (2006) 375-377
58. Huerva V., Sanchez M.C., and Mangues I. Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia. J Ocul Pharmacol Ther 23 (2007) 143-145
59. Stone D.U., Butt A.L., and Chodosh J. Ocular surface squamous neoplasia: a standard of care survey. Cornea 24 (2005) 297-300
60. Giaconi J.A., and Karp C.L. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf 1 (2003) 66-73
61. Shields C.L., Shields J.A., and Armstrong T. Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am J Ophthalmol 132 (2001) 576-578
62. Espana E.M., Prabhasawat P., Grueterich M., et al. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol 86 (2002) 640-645
63. Gunduz K., Ucakhan O.O., Kanpolat A., and Gunalp I. Nonpreserved human amniotic membrane transplantation for conjunctival reconstruction after excision of extensive ocular surface neoplasia. Eye 20 (2006) 351-357
64. Koreishi A.F., and Karp C.L. Ocular surface neoplasia. Focal Points 25 (2007) 1-14
65. Majewski S., Szmurlo A., Marczak M., et al. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines. Int J Cancer 57 (1994) 81-85
66. Gangemi J.D., Pirisi L., Angell M., and Kreider J.W. HPV replication in experimental models: effects of interferon. Antiviral Res 24 (1994) 175-190
67. Rubinfeld R.S., Pfister R.R., Stein R.M., et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 99 (1992) 1647-1654
68. Salomao D.R., Mathers W.D., Sutphin J.E., et al. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy. Ophthalmology 106 (1999) 1756-1760
69. Cartsburg O., Kallen C., Hillenkamp J., et al. Topical mitomycin C and radiation induce conjunctival DNA-polyploidy. Anal Cell Pathol 23 (2001) 65-74
70. Dogru M., Erturk H., Shimazaki J., et al. Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia. Cornea 22 (2003) 627-639
71. Dudney B.W., and Malecha M.A. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol 137 (2004) 950-951
72. Smith M., Trousdale M.D., Rao N.A., and Robin J.B. Lack of toxicity of a topical recombinant interferon alpha. Cornea 8 (1989) 58-61